
Rashi Pharma Care Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.90 Cr
- Revenue Growth 521.95%
- Profit Growth 186.85%
- Ebitda 185.42%
- Net Worth -34.99%
- Total Assets 175.54%
About Rashi Pharma Care
Rashi Pharma Care Private Limited (RPCPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 March 2021 (Three years and 11 months 16 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹5.90 Cr.
Shilpa Jain, Rashi Jain, Neeti Jain, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909MH2021PTC356923
- Company No.
356923
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Rashi Pharma Care?
Executive Team (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rashi Jain ![]() | Managing Director | 13-Mar-2021 | Current |
Shilpa Jain ![]() | Managing Director | 13-Mar-2021 | Current |
Neeti Jain ![]() | Managing Director | 13-Mar-2021 | Current |
Sanjay Jain ![]() | Managing Director | 13-Mar-2021 | Current |
Board Members

No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Rashi Pharma Care.
Rashi Pharma Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 521.95% increase. The company also saw a substantial improvement in profitability, with a 186.85% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.99%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Rashi Pharma Care?
Unlock access to Rashi Pharma Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Related Corporates (Common Directorship)
- Rvkg Solutions Private Limited
Rashi Jain is a mutual person
- F1fx Llp
Shilpa Jain and Rashi Jain are mutual person
- Shreen Biosciences Private Limited
Shilpa Jain and Sanjay Jain are mutual person
Charges (Loans)
₹59.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 5.90 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
11 Jan 2023 | Others | ₹3.75 Cr | Open |
30 Nov 2021 | Others | ₹2.15 Cr | Open |
How Many Employees Work at Rashi Pharma Care?
Rashi Pharma Care has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Rashi Pharma Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rashi Pharma Care's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.